Significant research demonstrate that Nadecenemab , a cutting-edge therapeutic , has the potential to slow the progression of mild Alzheimer's . This medication targets reducing beta-amyloid within https://socialmediainuk.com/story26687614/lecanemab-a-emerging-innovative-cognitive-treatment